CXCL9 antagonism further extends prolonged cardiac allograft survival in CCL19/CCL21-deficient mice.
about
IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival.The last 5 years of basic science investigation in transplant immunology.Dendritic cells and chemokine-directed migration in transplantation: where are we headed?An antibody to IP-10 is a potent antagonist of cell migration in vitro and in vivo and does not affect disease in several animal models of inflammation.
P2860
CXCL9 antagonism further extends prolonged cardiac allograft survival in CCL19/CCL21-deficient mice.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
CXCL9 antagonism further exten ...... in CCL19/CCL21-deficient mice.
@en
CXCL9 antagonism further exten ...... in CCL19/CCL21-deficient mice.
@nl
type
label
CXCL9 antagonism further exten ...... in CCL19/CCL21-deficient mice.
@en
CXCL9 antagonism further exten ...... in CCL19/CCL21-deficient mice.
@nl
prefLabel
CXCL9 antagonism further exten ...... in CCL19/CCL21-deficient mice.
@en
CXCL9 antagonism further exten ...... in CCL19/CCL21-deficient mice.
@nl
P2093
P2860
P1476
CXCL9 antagonism further exten ...... in CCL19/CCL21-deficient mice.
@en
P2093
Angus W Thomson
Bridget L Colvin
Hideki Nakano
Robert L Fairchild
Terutaka Kakiuchi
Zhiliang Wang
P2860
P304
P356
10.1111/J.1600-6143.2005.00996.X
P407
P577
2005-09-01T00:00:00Z